Citigroup »

Maia Biotechnology shares owned by Citigroup

Quarter-by-quarter ownership of Maia Biotechnology (MAIA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Maia Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Maia Biotechnology held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maia Biotechnology by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $31 22 1.41

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Maia Biotechnology

Vanguard Capital Management
Vanguard Group
Centric Wealth Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
State Street Corporation
UBS Group
Northern Trust
Bridgeway Capital Management
Creative Planning
Comprehensive Portfolio Management
O'shaughnessy Asset Management
Centerpoint Advisory Group
Susquehanna International

View all funds holding Maia Biotechnology